Insulet | PODD - 流动负债



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 480.4M
销售成本
USD 232.7M
流动资产
USD 1.71B
流动负债
USD 687.5M
债务
USD 949.2M
EBIT
USD 122M
EBITDA
USD 181.7M
员工
3.9K
EPS每股收益
USD 1.42
股本和储备
USD 1.3B
销售毛利
USD 540.8M
债务利息支出
USD 14.7M
利息收入
USD 5.7M
贷款资金
USD 929.5M
市值
USD 11.5B
净收入
USD 91.1M
营业费用
USD 639.7M
营业利润
USD 122M
普通股股本
USD 69.26M
PE价格收益
38.83
税前利润
USD 113M
销售收入
USD 761.7M
销售和管理费用
USD 317.2M
股票
USD 462.5M
贸易债权人
USD 149.8M
应收帐款人
USD 544.7M


流动负债 更改 日
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 14.16M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Avanos Medical USD 131.2M 34M 2026-03
Baxter International USD 3.69B 723M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Cardinal Health USD 41.99B 1.33B 2026-03
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Globus Medical USD 482.46M 16.04M 2026-03
ICU Medical USD 517.9M 19.04M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
J&J USD 57.72B 3.59B 2026-03
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 216.87M 22.89M 2026-03
Roche Holding CHF 28B 421M 2025-12
Solventum Corp USD 3.35B 210M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
West Pharmaceutical Services USD 674M 19.1M 2026-03
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03